Zobrazeno 1 - 10
of 74
pro vyhledávání: '"F. Inverardi"'
Autor:
A. Tincani, I. Cavazzana, A. Ceribelli, M. Fredi, F. Inverardi, M. Taraborelli, F. Franceschini
Publikováno v:
Reumatismo, Vol 64, Iss 5, Pp 321-325 (2012)
A small number of systemic lupus erythematosus (SLE) patients develop an erosive disease. Some studies have suggested an association between anti-cyclic citrullinated (anti-CCP) antibodies and this pattern of arthritis, but their exact significance i
Externí odkaz:
https://doaj.org/article/d661571ef44b4afdb9ddabb3025892da
Autor:
Maria Giulia Fenini, Angela Tincani, Francesca Regola, Francesco Ferrè, F. Inverardi, M. G. Lazzaroni, Paolo Airò, Mirko Scarsi, Roberto Furloni
Publikováno v:
J Scleroderma Relat Disord
Objectives: To investigate the epidemiology of systemic sclerosis in Valcamonica, an Italian Alpine valley, during an 18-year-long period. Methods: Patients with systemic sclerosis living in Valcamonica between 1999 and 2016 were identified by captur
Autor:
M.G. Fenini, Roberto Furloni, A. Premoli, M. G. Lazzaroni, Mirko Scarsi, F. Inverardi, Francesca Dall'Ara, Paolo Airò, Angela Tincani, S. Zingarelli
Publikováno v:
Saturday, 16 JUNE 2018.
Background Not much information is available on the variations in the incidence and prevalence of Systemic Sclerosis (SSc) over time. Objectives To investigate the epidemiology of SSc in Valcamonica, an Alpine valley in northern Italy (Brescia Provin
Autor:
F. Inverardi, Stefania Cartella, Franco Franceschini, Angela Tincani, Ilaria Cavazzana, Angela Ceribelli
Publikováno v:
Autoimmunity. 46:363-368
We retrospectively compared disease activity, treatment, clinical and laboratory features, and rate of mortality of 535 SLE patients with adult and late disease onset.patients were divided into two groups based on the onset of the disease before or a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Chiara Tani, Pier Luigi Meroni, Marta Mosca, Roberto Caporali, Laura Trespidi, Angela Tincani, Véronique Ramoni, Mario Motta, Maria Grazia Lazzaroni, Paolo Sfriso, Francesca Anna Letizia Strigini, Paola Caramaschi, Andrea Lojacono, Loïc Guillevin, F. Inverardi, Renato Alberto Sinico, Laura Andreoli, Micaela Fredi, Maria Gerosa, Antonio Brucato, Carlomaurizio Montecucco, Andrea Doria
Publikováno v:
Autoimmunity reviews. 14(8)
Objective: Systemic vasculitis (SV) are uncommon diseases that rarely affect women during their reproductive age; little data, mainly retrospective, is available on this topic. The aim of our study was to evaluate maternal/neonatal outcome and diseas
Autor:
V. Grosso, Nicola Boffini, F. Inverardi, Lorenzo Cavagna, Giovanni Cagnotto, Roberto Caporali
Publikováno v:
Mediators of Inflammation
Mediators of Inflammation, Vol 2012 (2012)
Mediators of Inflammation, Vol 2012 (2012)
In the last decades a large amount of evidence linked rheumatoid arthritis (RA) to atherosclerosis. In fact, RA patients have an increased risk of cardiovascular events that is not fully explained by other classic cardiovascular risk factors. RA and
Autor:
Carlomaurizio Montecucco, S. Breda, F. Inverardi, F. De Nard, Monica Todoerti, R. Caporali, Sara Monti, V. Grosso
Publikováno v:
Annals of the Rheumatic Diseases. 74:1036.3-1037
Background Actually, as suggested from current therapeutic guidelines, tapering of biologic agents (bDMARDs) seems a feasible option in subsets of rheumatoid arthritis (RA) patients in persistent clinical disease control [1]. However definite step-do
Autor:
E. Scorletti, F. Inverardi, Roberto Caporali, Fausto Baldanti, Giulia Campanini, Carlomaurizio Montecucco, Lorenzo Cavagna
Publikováno v:
Lupus. 22:1087-1088
Sir,Fever is one of the most challenging problems insystemic lupus erythematosus (SLE) and the fol-lowing example may be paradigmatical. A 53-year-old woman diagnosed with SLE (2001: fever,arthritis, subacute cutaneous lupus, anti-dsDNA,ANA and anti-
Autor:
Roberto Caporali, F. Benaglio, F. Inverardi, Laura Bogliolo, Carlomaurizio Montecucco, Giovanni Cagnotto, Antonio Manzo, Serena Bugatti
Publikováno v:
Annals of the Rheumatic Diseases. 73:405.3-406
Background Anti-citrullinated protein antibodies (ACPA) are a major risk factor for bone destruction in rheumatoid arthritis (RA). ACPA may directly induce bone loss by stimulating osteoclast differentiation [1]. Accordingly, the trabecular bone micr